|
Registration benefits include:
|
|
Access to CME/CE programs and certification
|
|
|
Free subscription to Biologic Bulletin newsletter
|
|
|
Reminders of new CME/CE activities
|
 REGISTER NOW
|
|
This Web site is supported by an
unrestricted educational grant from
Genentech, Inc.
|
|
|
|
 |
| |
PsoriasisTx is a free educational Web site designed to provide dermatologists and dermatology nurses with the latest information about biologic therapies used to treat patients with moderate to severe psoriasis.
WHAT'S NEW
CME SPOTLIGHT
|
|
The Impact of Weight on Long-Term Success in Psoriasis Treatment
CME-Certified Internet Enduring Activity
Archive of a CME Web teleconference series held June–August 2007
Release Date: October 2007
It is important for dermatologists to learn about the comorbidities commonly found in psoriasis patients who are obese, as well as the other weight-related factors that may affect the treatment outcome of psoriasis patients who receive biologic therapy. This CME activity explores the data on obesity and psoriasis and will further educate dermatologists on the effect of weight on successful treatment of this patient population.
Co-sponsored by the Dannemiller Memorial Educational Foundation and Curatio CME Institute
Support for this activity has been provided through an educational grant from Genentech, Inc.
Access this activity by clicking on Read More link below.
|
|
READ MORE
|
|
EXPERT PRACTICE HIGHLIGHT
|
 |
Using Biologic Agents in Combination With Other Systemic Therapies in Psoriasis Patients
CME-Certified Expert Practice Article
An interview with Jennifer C. Cather, MD
The overwhelming majority of clinical trial data on the efficacy and safety of biologics in psoriasis treatment focuses on monotherapy. Consequently, many dermatologists assume that biologics cannot be combined with other systemic psoriasis treatments. In this Expert Practice, Jennifer C. Cather, MD, a dermatologist in practice at Modern Dermatology in Dallas, Texas, discusses the suitability of combining biologics with other types of psoriasis treatments, such as methotrexate, cyclosporine, or ultraviolet light. This article focuses on the ways that combination therapy with biologic and systemic agents can offer new strategies for improved management of psoriasis.
|
| READ MORE |
|
|
 |
New Biologic Agents in Development for Psoriasis
CME-Certified Expert Practice Article
An interview with Gerald G. Krueger, MD
There is considerable excitement surrounding several new biologic agents with novel mechanisms of action and their potential as treatments for psoriasis. We recently interviewed Gerald G. Krueger, MD, Professor of Dermatology at the University of Utah in Salt Lake City, to gain his insights on the emerging data for these agents. In this Expert Practice, Dr. Krueger discusses the mechanisms of action of these agents in development, as well as the clinical data reported to date.
|
| READ MORE |
|
MEETING SPOTLIGHT
|
|
Perspectives on Biologic Agents and Psoriasis: Update From the American Academy of Dermatology's Summer Academy Meeting
CME-Certified Meeting Report
Edited by: Neil J. Korman, MD, PhD
The American Academy of Dermatology (AAD) held its 2007 Summer Academy Meeting in Manhattan on August 1–5. The event featured a variety of posters relating to psoriasis research, the most relevant of which have been chosen for review in this activity. Topics of importance included efficacy and safety updates on individual biologics, combination therapy using biologics, the influence of biologic therapy on quality-of-life measures, and newly released clinical efficacy data on an IL-12/23 antibody. In addition, Neil J. Korman, MD, PhD, Professor of Dermatology and Clinical Director of the Murdough Family Center for Psoriasis at University Hospitals Case Medical Center in Cleveland, provides commentary on specific posters or groups of posters in order to better define the clinical importance of the presented research data. The purpose of this activity is to provide physicians who were unable to attend the 2007 Summer Academy meeting a summary of the most important poster presentations focusing on psoriasis.
|
| READ MORE |
|
|
|
|
|
